CAS 1227939-82-3: Ilorasertib

Description:Ilorasertib, with the CAS number 1227939-82-3, is a small molecule inhibitor primarily targeting the protein kinase activity of certain members of the Aurora kinase family, which play a crucial role in cell division and mitosis. This compound is characterized by its potential application in cancer therapy, particularly in the treatment of various malignancies where aberrant cell division is a hallmark. Ilorasertib exhibits selective inhibition, which may lead to reduced side effects compared to less specific chemotherapeutic agents. Its mechanism of action involves disrupting the normal function of Aurora kinases, thereby inducing cell cycle arrest and apoptosis in cancer cells. The compound is typically administered in a clinical setting, and its efficacy and safety profile are evaluated through rigorous clinical trials. As with many targeted therapies, the development of resistance and the identification of biomarkers for patient selection are critical areas of ongoing research. Overall, Ilorasertib represents a promising avenue in the field of targeted cancer therapies.

Found 4 products.

Product data	Purity	Price range	Estimated delivery
Ilorasertib REF: 54-BUP09072CAS: 1227939-82-3	98.02%	263.00 €~1,711.00 €	Wed 16 Apr 25
Ilorasertib REF: TM-TQ0059CAS: 1227939-82-3	96.17% - 98.03%	39.00 €~567.00 €	Tue 22 Apr 25
ABT-348 REF: 4Z-A-181001CAS: 1227939-82-3	- - -	To inquire	Tue 22 Apr 25
Ilorasertib REF: 3D-FI104157CAS: 1227939-82-3	Min. 95%	- - -	Discontinued product